Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aziz Ould Ismail

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|May 13, 2022
Using electronic health records to streamline provider recruitment for implementation science studiesChiamaka L Okorie, Elise Gatsby, Florian R Schroeck, et al.
Implementation Science : IS|September 1, 2022
Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillanceFlorian R Schroeck, A Aziz Ould Ismail, David A Haggstrom, et al.
Academic Pathology|June 30, 2026
Evaluating artificial intelligence-generated multiple-choice questions in clinical pathologyA Aziz Ould Ismail, Weijie Ma, Nancy M Dunbar, et al.
Cancer Cytopathology|May 18, 2026
Lung adenocarcinoma with malignant serous effusions: A comprehensive clinicopathologic, molecular, and outcome analysisWeijie Ma, Jiannan Li, A Aziz Ould Ismail, et al.
European Urology Open Science|April 1, 2024
Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent CystoscopyFlorian R Schroeck, Robert Grubb, Todd A MacKenzie, et al.
European Urology Open Science|August 2, 2021
Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non-muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?Michael E Rezaee, A Aziz Ould Ismail, Chiamaka L Okorie, et al.
Urology|September 3, 2023
Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs StudyVikram Lyall, A Aziz Ould Ismail, David A Haggstrom, et al.
JCO Oncology Practice|August 31, 2021
Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases FrameworkFlorian R Schroeck, A Aziz Ould Ismail, Grace N Perry, et al.
Head & Neck|April 23, 2026
The Utility of Comprehensive Sampling in Cervical Lymph Node Dissection for Head and Neck Squamous Cell Carcinoma: Is More Better?A Aziz Ould Ismail, Jason R Pettus, Laura J Tafe, et al.
Implementation Science Communications|April 8, 2025
Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational studyLisa Zubkoff, A Aziz Ould Ismail, Laura Jensen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|May 13, 2022
Using electronic health records to streamline provider recruitment for implementation science studiesChiamaka L Okorie, Elise Gatsby, Florian R Schroeck, et al.
Implementation Science : IS|September 1, 2022
Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillanceFlorian R Schroeck, A Aziz Ould Ismail, David A Haggstrom, et al.
Academic Pathology|June 30, 2026
Evaluating artificial intelligence-generated multiple-choice questions in clinical pathologyA Aziz Ould Ismail, Weijie Ma, Nancy M Dunbar, et al.
Cancer Cytopathology|May 18, 2026
Lung adenocarcinoma with malignant serous effusions: A comprehensive clinicopathologic, molecular, and outcome analysisWeijie Ma, Jiannan Li, A Aziz Ould Ismail, et al.
European Urology Open Science|April 1, 2024
Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent CystoscopyFlorian R Schroeck, Robert Grubb, Todd A MacKenzie, et al.
European Urology Open Science|August 2, 2021
Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non-muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?Michael E Rezaee, A Aziz Ould Ismail, Chiamaka L Okorie, et al.
Urology|September 3, 2023
Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs StudyVikram Lyall, A Aziz Ould Ismail, David A Haggstrom, et al.
JCO Oncology Practice|August 31, 2021
Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases FrameworkFlorian R Schroeck, A Aziz Ould Ismail, Grace N Perry, et al.
Head & Neck|April 23, 2026
The Utility of Comprehensive Sampling in Cervical Lymph Node Dissection for Head and Neck Squamous Cell Carcinoma: Is More Better?A Aziz Ould Ismail, Jason R Pettus, Laura J Tafe, et al.
Implementation Science Communications|April 8, 2025
Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational studyLisa Zubkoff, A Aziz Ould Ismail, Laura Jensen, et al.
Pageof 1